Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VLO vs GSK✓SelectedUSD · GSKVLO vs GSK performance historyLatest closeAs of-5.52%11/18
Stock and ETF performance explorer

VLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+443.0%
GSK return
+42.7%
Excess return
+400.4%
Maximum drawdown
-41.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.5%-1.3%-4.2%-5.4%
7D-5.5%-3.1%-2.4%-5.3%
30D-20.7%-0.9%-19.8%-20.6%
3M-1.8%-4.2%+2.4%-1.5%
6M+34.1%-1.6%+35.7%+33.9%
YTD+114.3%+2.6%+111.7%+110.2%
1Y+89.3%+6.2%+83.1%+84.4%
3Y+198.3%+55.0%+143.3%+162.5%
5Y+443.0%+42.8%+400.2%+362.6%
All+443.0%+42.7%+400.4%+362.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling